Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix. Zhang SW, Luo RZ, Sun XY, Yang X, et al. BMC Cancer 2021;21:332.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang SW, Luo RZ, Sun XY, Yang X, et al. Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix. BMC Cancer 2021;21:332.
PMID: 33789601